Literature DB >> 2129093

Epilepsy following neurosurgical intervention.

S A O'Laoire1.   

Abstract

The incidence of post-surgical epilepsy has been reported to be very high, and related to the pathological condition, to the surgery itself, and, particularly in the case of aneurysms, to the site of the lesion. Prophylactic anti-convulsant medication has been widely recommended on the basis of the perceived high risk of epilepsy. A prospective analysis of one hundred consecutive survivors of aneurysm surgery treated in a consistent microsurgical manner was performed to assess the incidence and causation of post-operative seizures. Three patients had a single early post-operative seizure. All three had predisposing features; a previous epileptic history in two, and neurological deficit in the other. Only one patient developed repeated seizures (epilepsy); he had major parenchymal damage. Seizures did not occur during a two to six year follow up in survivors of aneurysm surgery who did not have a previous epileptic history or a persistent post-operative neurological deficit. The site of aneurysm did not influence the development of epilepsy, and middle cerebral aneurysms were not associated with an increased risk. The low risk of epilepsy does not justify routine anti-convulsant prophylaxis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2129093

Source DB:  PubMed          Journal:  Acta Neurochir Suppl (Wien)


  3 in total

Review 1.  Seizures and anticonvulsants after aneurysmal subarachnoid hemorrhage.

Authors:  Giuseppe Lanzino; Pietro Ivo D'Urso; Jose Suarez
Journal:  Neurocrit Care       Date:  2011-09       Impact factor: 3.210

2.  Peri-operative prophylaxis with phenytoin: dosage and therapeutic plasma levels.

Authors:  A Levati; G Savoia; F Zoppi; L Boselli; C Tommasino
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

3.  Levetiracetam compared with valproic acid for the prevention of postoperative seizures after supratentorial tumor surgery: a retrospective chart review.

Authors:  Young Jin Lee; Tackeun Kim; So Hyun Bae; Young-Hoon Kim; Jung Ho Han; Chang-Ho Yun; Chae-Yong Kim
Journal:  CNS Drugs       Date:  2013-09       Impact factor: 5.749

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.